Stem Cell Therapy International, Inc. (SCII.OB) Prepared to Repeat Histostem’s Success in South Korea on an International Scale
Stem Cell Therapy International, Inc. - soon to be known as AmStem International after merging with Histostem Ltd, of South Korea – was proud to announce this morning that the company is now ready to replicate, on an international scale, the successful Stem Cell Leadership Program developed by Dr. Hoon Han in South Korea. Stem Cell Therapy and Histostem Ltd. management will work together to establish a dynamic system of stem cell collection, storage, research and therapeutic services, based on the proven success of Histostem, Ltd. in Asia. "We will be creating a mentoring system from AmStem's proprietary technologies (as…